ARTICLE | Clinical News
Biosimilar infliximab: Additional Phase III data
June 20, 2016 7:00 AM UTC
Data from 396 patients with moderate to severe RA despite methotrexate therapy who were re-randomized at week 54 to either transition from Remicade infliximab to Flixabi (n=94) or remain on treatmen...